$9.46
0.262.83%
At close: May 15, 5:00 PM EST
$9.46
N/A
After Hours: May 15, 4:01 PM EST
Beta Bionics Inc Stock Guidance
BBNXNASDAQ
Beta Bionics (BBNX) last issued guidance on April 21, 2026 for fiscal year 2026. The company guided revenue in the range of $131.00M - $136.00M for the period.
Compared to prior guidance, Beta Bionics maintained its revenue forecast from a prior range of $130.00M - $135.00M.
Beta Bionics has issued 5 guidance updates between March 25, 2025 and April 21, 2026. During this period, the company raised its outlook 3 times, reflecting management's growing confidence in business performance.
Latest Guidance Date
Apr 21, 2026
Guidance Period
Full Year 2026
Revenue Guidance Range
$131.00M - $136.00M
Beta Bionics Guidance History
Review all historical guidance issued by Beta Bionics, including EPS and revenue forecasts across quarterly and annual periods.
Loading calendar...
FAQ
What is the most recent guidance for Beta Bionics (BBNX)?
The most recent guidance for Beta Bionics (BBNX) was reported on April 21, 2026 for the fiscal year 2026. Beta Bionics forecasted revenue between $131.00M and $136.00M for the period.
What revenue range did Beta Bionics (BBNX) guide for?
Beta Bionics (BBNX) guided revenue in the range of $131.00M to $136.00M for the fiscal year 2026.
Did Beta Bionics (BBNX) raise or lower guidance?
Beta Bionics (BBNX) maintained its revenue guidance from a prior range of $130.00M - $135.00M to $131.00M - $136.00M for the fiscal year 2026.
When did Beta Bionics (BBNX) last issue guidance?
Beta Bionics (BBNX) last issued guidance on April 21, 2026 for the fiscal year 2026.
